Neurology & Neurosurgery Research
ARCADIA Study
AtRial Cardiopathy and Antithrombotic Drugs in Prevention after Cryptogenic Stroke (ARCADIA)
AGE: 45 years and older
SEX AT BIRTH: All
SEX AT BIRTH: All
TYPE: Investigational Drug Study
CONDITION: Stroke
CONDITION: Stroke
HEALTHY PARTICIPANTS: No
LOCATION: UH Cleveland Medical Center
LOCATION: UH Cleveland Medical Center
Learn More About This Research Study
For more information, please contact study coordinator, Mary Andrews at 216-844-2386 and leave a message or complete the online form below.
Study Purpose
The purpose of this research study is to compare the effects (good and bad) of the ARCADIA study drugs (apixaban and aspirin) on the occurrence of silent strokes and memory loss after stroke.
Who Can Participate
Participants 45 years and older diagnosed with a stroke maybe eligible for this study.